Examination of The Relationshıp Between Body Mass Index And The Skin-Epidural Space Distance

NCT ID: NCT06316622

Last Updated: 2024-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-08

Study Completion Date

2022-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim: The aim of the study; to investigate whether there is a relationship between body mass index (BMI), waist circumference, and abdominal subcutaneous adipose tissue and the skin-epidural space distance measured by USG.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The research was carried out in the block room in the preoperating room of Dokuz Eylül University Practice and Research Hospital and with 42 volunteer operating room workers aged between 18-59 years. Height, weight and waist circumference measurements were made with standard measuring instruments, and other measurements were completed by ultrasonography (USG) separately by an anesthesiologist and a radiologist. For ultrasonographic evaluation, left lateral decubitus, right lateral decubitus and in sitting position, skin-dural junction, skin-vertebra corpus, anterior complex distances, upper and lower SIAS levels were examined with convex probe as transverse median. In addition, abdominal subcutaneous fat thickness measurements were made with a linear probe in the supine position. The statistical correlations of all measurements were examined.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia Awareness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

relationship between body mass index and the skin epidural space distance
Primary Study Purpose

OTHER

Blinding Strategy

NONE

relationship between body mass index and the skin epidural space distance

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

volunteer person

meausered by ultrasound

Group Type EXPERIMENTAL

ultrasound

Intervention Type DEVICE

measured by ultrasound

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasound

measured by ultrasound

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age between 18 and 59 years old.
2. ASA I-II classification.
3. Body Mass Index (BMI): 18.5-29.9 kg/m2.

Exclusion Criteria

1. Individuals under 18 or over 59 years old.
2. Those with a history of vertebral surgery.
3. Patients diagnosed with spinal deformities (excluding scoliosis ≤10 degrees, kyphosis \<30 or \>80 degrees).
4. Individuals with rheumatologic diseases affecting skeletal structure such as ankylosing spondylitis, rheumatoid arthritis.
5. Presence of wounds or infections in the lumbar region.
6. Volunteers who underwent epidural or spinal interventions in the lumbar region within the last month.
7. Individuals with bone implants affecting posture, such as hip or knee prostheses.
8. Pregnant women.
9. Individuals with conditions like Cushing's syndrome, hypothyroidism, acromegaly causing lumbar edema.
10. Volunteers using corticosteroids.
11. Obese individuals (BMI: \>29.9).
Minimum Eligible Age

21 Years

Maximum Eligible Age

58 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dokuz Eylul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Damla Kaytancı

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Semih Küçükgüçlü, doctor

Role: STUDY_CHAIR

Dokuz Eylul University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dokuz Eylul Unicersity

Izmir, Narlidere, Turkey (Türkiye)

Site Status

Dokuz Eylul University

Izmir, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021/08/42

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.